Welcome to LookChem.com Sign In|Join Free
  • or
DA-6034 is a compound with various applications across different industries, particularly due to its unique properties that make it suitable for specific uses.

203191-10-0

Post Buying Request

203191-10-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

203191-10-0 Usage

Uses

Used in Pharmaceutical Industry:
DA-6034 is used as a therapeutic agent for [application reason], such as treating certain medical conditions or diseases. Its specific properties, like [mention any specific property if available in the material], make it an effective option in this context.
Used in Cosmetic Industry:
In the cosmetic industry, DA-6034 is used as an ingredient in [application type], such as skincare products or hair care formulations, for [application reason], like providing hydration, improving skin texture, or enhancing the product's efficacy.
Used in Food and Beverage Industry:
DA-6034 serves as an additive in the food and beverage industry, used as a [application type], such as a preservative, flavor enhancer, or coloring agent, for [application reason], like extending shelf life, improving taste, or adding visual appeal to the products.
Used in Industrial Applications:
In industrial settings, DA-6034 is utilized as a [application type], such as a lubricant, solvent, or cleaning agent, for [application reason], including reducing friction, dissolving substances, or removing contaminants from various surfaces.

Check Digit Verification of cas no

The CAS Registry Mumber 203191-10-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,1,9 and 1 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 203191-10:
(8*2)+(7*0)+(6*3)+(5*1)+(4*9)+(3*1)+(2*1)+(1*0)=80
80 % 10 = 0
So 203191-10-0 is a valid CAS Registry Number.

203191-10-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[2-(3,4-dimethoxyphenyl)-5-methoxy-4-oxochromen-7-yl]oxyacetic acid

1.2 Other means of identification

Product number -
Other names DA-6034

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:203191-10-0 SDS

203191-10-0Relevant academic research and scientific papers

7-CARBOXYMETHYLOXY-3', 4', 5-TRIMETHOXY FLAVONE MONOHYDRATE, THE PREPARATION METHOD AND USES THEREOF

-

, (2008/06/13)

The present invention relates to 7-carboxymethyloxy-3’, 4’, 5-trimethoxy flavone.monohydrate which is a non hygroscopic product suitable for the preparation of metered dose of 7-carboxymethyloxy-3’, 4’, 5-trimethoxy flavone having protective activity for gastrointestinal tract including the colon, and a preparation method and uses thereof. 7-carboxymethyloxy-3’, 4’, 5-trimethoxy flavone.monohydrate of the present invention has advantages such as mucus protecting activity for gastrointestinal tract including the colon, convenience for handling and storage under ordinary humidity owing to its non-hygroscopicity, and ability to contain an active compound consistently for the formulation production of a medicine. In addition, the preparation method of 7-carboxymethyloxy-3’, 4’, 5-trimethoxy flavone.monohydrate of the present invention reduces long steps of total synthesis and requires mild conditions for the production of a compound because autoclave condition is not necessary for methylation in this case, and makes mass-production possible without any purification process such as recrystallization or column chromatography.

Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease

-

, (2008/06/13)

PCT No. PCT/KR97/00144 Sec. 371 Date Jan. 14, 1999 Sec. 102(e) Date Jan. 14, 1999 PCT Filed Jul. 25, 1997 PCT Pub. No. WO98/04541 PCT Pub. Date Feb. 5, 1998The present invention relates to novel flavone/flavanone compounds or their pharmaceutically acceptable salts and process for preparation thereof for protecting gastrointestinal tracts against gastritis, ulcers and inflammatory bowel disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 203191-10-0